{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:36:56Z","timestamp":1781545016145,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Evaluate the response to adalimumab (ADA) in pediatric chronic anterior uveitis (pCAU).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospective chart review of pCAU patients treated with ADA. Outcomes evaluated included the proportion of patients achieving zero ocular inflammation and discontinuation of topical corticosteroids, visual outcomes, and incidence of uveitis recurrences after\u2009\u2265\u200912\u00a0months of prescribing ADA. Incidence and risk factors for developing anti-adalimumab antibodies (AAAs) were also evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 27 children aged 11\u00a0years, 16 (59%) were Caucasian and 6 (22%) African Americans. Thirteen (48%) patients had idiopathic pCAU, 12 (44%) had juvenile idiopathic arthritis (JIA) related pCAU, and 2 (7%) had tubulointerstitial nephritis and uveitis syndrome. At baseline, African American children had worse visual acuity (<jats:italic>p<\/jats:italic>\u2009=\u20090.026). At 1\u00a0year, 21 (78%) children achieved zero ocular inflammation (remission). Risk factors associated with non-remission were being African American (20% vs. 94%, <jats:italic>p<\/jats:italic>\u2009=\u20090.003) and experiencing\u2009\u2265\u20091 episode of uveitis recurrence (100% vs. 0%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Six episodes of uveitis recurrence were documented in five children, four of whom were African American. Topical corticosteroids were discontinued in 83% of children, and visual acuity remained stable for 1\u00a0year. Twelve children were tested for AAAs due to arthritis or uveitis flare-ups, with five (42%) being positive. No significant factors were associated with the development of AAAs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We found that ADA is effective in controlling inflammation, reducing the need for topical corticosteroids, and maintaining visual acuity in pCAU. There appears to be racial differences in African American children who had worse baseline disease and poorer outcomes. Studies are necessary to understand better and address these disparities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10792-024-03289-1","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T15:02:55Z","timestamp":1725980575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-2395","authenticated-orcid":false,"given":"Raul E.","family":"Ruiz-Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4213-7358","authenticated-orcid":false,"given":"Hazem M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Soifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim S.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5237-240X","authenticated-orcid":false,"given":"Manuel E.","family":"Quiroga-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daliya","family":"Dzhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Egla","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-0847","authenticated-orcid":false,"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"3289_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/BOR.0b013e328349c324","volume":"23","author":"CE Rabinovich","year":"2011","unstructured":"Rabinovich CE (2011) Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update. Curr Opin Rheumatol 23:432\u2013436. https:\/\/doi.org\/10.1097\/BOR.0b013e328349c324","journal-title":"Curr Opin Rheumatol"},{"key":"3289_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/BOR.0000000000000316","volume":"28","author":"ST Angeles-Han","year":"2016","unstructured":"Angeles-Han ST, Rabinovich CE (2016) Uveitis in children. Curr Opin Rheumatol 28:544\u2013549. https:\/\/doi.org\/10.1097\/BOR.0000000000000316","journal-title":"Curr Opin Rheumatol"},{"key":"3289_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23871","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J (2019) 2019 American college of rheumatology\/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken) 71:703\u2013716. https:\/\/doi.org\/10.1002\/acr.23871","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3289_CR4","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.ophtha.2006.05.016","volume":"113","author":"LI Kump","year":"2006","unstructured":"Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS (2006) Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology 113:1874\u20131877. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.016","journal-title":"Ophthalmology"},{"key":"3289_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA (2007) Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 143:840\u2013846. https:\/\/doi.org\/10.1016\/j.ajo.2007.01.033","journal-title":"Am J Ophthalmol"},{"key":"3289_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1936565","author":"KM McKay","year":"2021","unstructured":"McKay KM, Apostolopoulos N, Chou B, Leveque TK, Van Gelder RN (2021) Anti-adalimumab antibodies in patients with non-infectious ocular inflammatory disease: a case series. Ocul Immunol Inflamm. https:\/\/doi.org\/10.1080\/09273948.2021.1936565","journal-title":"Ocul Immunol Inflamm"},{"key":"3289_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40272-015-0128-2","volume":"17","author":"MA Lerman","year":"2015","unstructured":"Lerman MA, Rabinovich CE (2015) The future is now: biologics for non-infectious pediatric anterior uveitis. Paediatr Drugs 17:283\u2013301. https:\/\/doi.org\/10.1007\/s40272-015-0128-2","journal-title":"Paediatr Drugs"},{"key":"3289_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40259-015-0134-5","volume":"29","author":"SS Thomas","year":"2015","unstructured":"Thomas SS, Borazan N, Barroso N, Duan L, Taroumian S, Kretzmann B, Bardales R, Elashoff D, Vangala S, Furst DE (2015) Comparative immunogenicity of TNF inhibitors: impact on clinical efficacy and tolerability in the management of autoimmune diseases. A systematic review and meta-analysis. BioDrugs 29:241\u2013258. https:\/\/doi.org\/10.1007\/s40259-015-0134-5","journal-title":"BioDrugs"},{"key":"3289_CR9","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1136\/annrheumdis-2012-202220","volume":"72","author":"S Garces","year":"2013","unstructured":"Garces S, Demengeot J, Benito-Garcia E (2013) The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis. Ann Rheum Dis 72:1947\u20131955. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202220","journal-title":"Ann Rheum Dis"},{"key":"3289_CR10","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.ophtha.2016.08.025","volume":"123","author":"M Cordero-Coma","year":"2016","unstructured":"Cordero-Coma M, Calleja-Antolin S, Garzo-Garcia I, Nunez-Garnes AM, Alvarez-Castro C, Franco-Benito M, Ruiz de Morales JG (2016) Adalimumab for treatment of noninfectious uveitis: immunogenicity and clinical relevance of measuring serum drug levels and antidrug antibodies. Ophthalmology 123:2618\u20132625. https:\/\/doi.org\/10.1016\/j.ophtha.2016.08.025","journal-title":"Ophthalmology"},{"key":"3289_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ, Dick AD, Brezin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, Chu DS, Camez A, Kwatra NV, Song AP, Kron M, Tari S, Suhler EB (2016) Adalimumab in patients with active noninfectious uveitis. N Engl J Med 375:932\u2013943. https:\/\/doi.org\/10.1056\/NEJMoa1509852","journal-title":"N Engl J Med"},{"key":"3289_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, Schlaen A, Pavesio C, Cimino L, Van Calster J, Camez AA, Kwatra NV, Song AP, Kron M, Tari S, Brezin AP (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388:1183\u20131192. https:\/\/doi.org\/10.1016\/S0140-6736(16)31339-3","journal-title":"Lancet"},{"key":"3289_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10067-019-04798-6","volume":"39","author":"JB Brunelli","year":"2020","unstructured":"Brunelli JB, Silva CA, Pasoto SG, Saa CGS, Kozu KT, Goldenstein-Schainberg C, Leon EP, Vendramini MBG, Fontoura N, Bonfa E, Aikawa NE (2020) Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching. Clin Rheumatol 39:515\u2013521. https:\/\/doi.org\/10.1007\/s10067-019-04798-6","journal-title":"Clin Rheumatol"},{"key":"3289_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/archdischild-2018-315060","volume":"104","author":"A Skrabl-Baumgartner","year":"2019","unstructured":"Skrabl-Baumgartner A, Seidel G, Langner-Wegscheider B, Schlagenhauf A, Jahnel J (2019) Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis. Arch Dis Child 104:246\u2013250. https:\/\/doi.org\/10.1136\/archdischild-2018-315060","journal-title":"Arch Dis Child"},{"key":"3289_CR15","first-page":"1043","volume":"35","author":"ST Leinonen","year":"2017","unstructured":"Leinonen ST, Aalto K, Kotaniemi KM, Kivela TT (2017) Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis. Clin Exp Rheumatol 35:1043\u20131046","journal-title":"Clin Exp Rheumatol"},{"key":"3289_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","volume":"247","author":"C Lange","year":"2009","unstructured":"Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M (2009) Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the freiburg visual acuity test (FrACT). Graefes Arch Clin Exp Ophthalmol 247:137\u2013142. https:\/\/doi.org\/10.1007\/s00417-008-0926-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3289_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"3289_CR18","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","volume":"52","author":"G Simonini","year":"2013","unstructured":"Simonini G, Paudyal P, Jones GT, Cimaz R, Macfarlane GJ (2013) Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology (Oxford) 52:825\u2013831. https:\/\/doi.org\/10.1093\/rheumatology\/kes186","journal-title":"Rheumatology (Oxford)"},{"key":"3289_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, Hardwick B, Hickey H, Hughes D, Woo P, Benton D, Edelsten C, Beresford MW, Group SS (2017) Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med 376:1637\u20131646. https:\/\/doi.org\/10.1056\/NEJMoa1614160","journal-title":"N Engl J Med"},{"issue":"919\u2013928","key":"3289_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.08.002","volume":"160","author":"ST Angeles-Han","year":"2015","unstructured":"Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Travers C, Rouster-Stevens K, Vogler LB, Lambert SR, Drews-Botsch C, Prahalad S (2015) The association of race with childhood uveitis. Am J Ophthalmol 160(919\u2013928):e911. https:\/\/doi.org\/10.1016\/j.ajo.2015.08.002","journal-title":"Am J Ophthalmol"},{"key":"3289_CR21","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1136\/bjophthalmol-2018-312048","volume":"103","author":"K Chauhan","year":"2019","unstructured":"Chauhan K, Scaife S, Rosenbaum JT (2019) Uveitis and health disparities: results from the national inpatient sample. Br J Ophthalmol 103:1301\u20131305. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312048","journal-title":"Br J Ophthalmol"},{"key":"3289_CR22","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1542\/peds.2006-0421","volume":"117","author":"J Cassidy","year":"2006","unstructured":"Cassidy J, Kivlin J, Lindsley C, Nocton J, Section on R, Section on O (2006) Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 117:1843\u20131845. https:\/\/doi.org\/10.1542\/peds.2006-0421","journal-title":"Pediatrics"},{"key":"3289_CR23","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/art.22709","volume":"56","author":"RK Saurenmann","year":"2007","unstructured":"Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, Silverman ED (2007) Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 56:1974\u20131984. https:\/\/doi.org\/10.1002\/art.22709","journal-title":"Arthritis Rheum"},{"key":"3289_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12969-015-0018-8","volume":"13","author":"ST Angeles-Han","year":"2015","unstructured":"Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Rouster-Stevens K, Vogler LB, Lambert SR, Drews-Botsch C, Prahalad S (2015) Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis. Pediatr Rheumatol Online J 13:19. https:\/\/doi.org\/10.1186\/s12969-015-0018-8","journal-title":"Pediatr Rheumatol Online J"},{"key":"3289_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/bjo.65.5.329","volume":"65","author":"RB Nussenblatt","year":"1981","unstructured":"Nussenblatt RB, Mittal KK (1981) Iridocyclitis in black Americans: association with HLA B8 suggests an autoimmune aetiology. Br J Ophthalmol 65:329\u2013332. https:\/\/doi.org\/10.1136\/bjo.65.5.329","journal-title":"Br J Ophthalmol"},{"key":"3289_CR26","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1001\/jama.1990.03440170066038","volume":"263","author":"Council on E, Judicial A","year":"1990","unstructured":"Council on E, Judicial A (1990) Black-white disparities in health care. JAMA 263:2344\u20132346. https:\/\/doi.org\/10.1001\/jama.1990.03440170066038","journal-title":"JAMA"},{"key":"3289_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaapos.2013.06.009","volume":"17","author":"L Bravo-Ljubetic","year":"2013","unstructured":"Bravo-Ljubetic L, Peralta-Calvo J, Noval S, Pastora-Salvador N, Abelairas-Gomez J, Merino R (2013) Adalimumab therapy for refractory childhood uveitis. J AAPOS 17:456\u2013459. https:\/\/doi.org\/10.1016\/j.jaapos.2013.06.009","journal-title":"J AAPOS"},{"key":"3289_CR28","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ajo.2007.08.018","volume":"144","author":"SP Ardoin","year":"2007","unstructured":"Ardoin SP, Kredich D, Rabinovich E, Schanberg LE, Jaffe GJ (2007) Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up. Am J Ophthalmol 144:844\u2013849. https:\/\/doi.org\/10.1016\/j.ajo.2007.08.018","journal-title":"Am J Ophthalmol"},{"key":"3289_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/03009742.2015.1022213","volume":"44","author":"A Skrabl-Baumgartner","year":"2015","unstructured":"Skrabl-Baumgartner A, Erwa W, Muntean W, Jahnel J (2015) Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response. Scand J Rheumatol 44:359\u2013362. https:\/\/doi.org\/10.3109\/03009742.2015.1022213","journal-title":"Scand J Rheumatol"},{"key":"3289_CR30","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/acr.22214","volume":"66","author":"G Simonini","year":"2014","unstructured":"Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT (2014) Current evidence of anti-tumor necrosis factor alpha treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs. Arthritis Care Res (Hoboken) 66:1073\u20131084. https:\/\/doi.org\/10.1002\/acr.22214","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3289_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1136\/bjo.2007.124081","volume":"91","author":"M Gallagher","year":"2007","unstructured":"Gallagher M, Quinones K, Cervantes-Castaneda RA, Yilmaz T, Foster CS (2007) Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol 91:1341\u20131344. https:\/\/doi.org\/10.1136\/bjo.2007.124081","journal-title":"Br J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03289-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03289-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03289-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:31:58Z","timestamp":1741879918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03289-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3289"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03289-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was previously approved, following tenets of the Declaration of Helsinki, by the Institutional Review Board of Duke University School of Medicine (Protocol Number: Pro00095121).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"376"}}